258 related articles for article (PubMed ID: 34506134)
1. Discovery of a Potent Glutathione Peroxidase 4 Inhibitor as a Selective Ferroptosis Inducer.
Xu C; Xiao Z; Wang J; Lai H; Zhang T; Guan Z; Xia M; Chen M; Ren L; He Y; Gao Y; Zhao C
J Med Chem; 2021 Sep; 64(18):13312-13326. PubMed ID: 34506134
[TBL] [Abstract][Full Text] [Related]
2. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
3. Solasonine promotes ferroptosis of hepatoma carcinoma cells via glutathione peroxidase 4-induced destruction of the glutathione redox system.
Jin M; Shi C; Li T; Wu Y; Hu C; Huang G
Biomed Pharmacother; 2020 Sep; 129():110282. PubMed ID: 32531676
[TBL] [Abstract][Full Text] [Related]
4. Boosting the Ferroptotic Antitumor Efficacy via Site-Specific Amplification of Tailored Lipid Peroxidation.
An Y; Zhu J; Liu F; Deng J; Meng X; Liu G; Wu H; Fan A; Wang Z; Zhao Y
ACS Appl Mater Interfaces; 2019 Aug; 11(33):29655-29666. PubMed ID: 31359759
[TBL] [Abstract][Full Text] [Related]
5. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q
J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
[TBL] [Abstract][Full Text] [Related]
7. A potent GPX4 degrader to induce ferroptosis in HT1080 cells.
Song H; Liang J; Guo Y; Liu Y; Sa K; Yan G; Xu W; Xu W; Chen L; Li H
Eur J Med Chem; 2024 Feb; 265():116110. PubMed ID: 38194774
[TBL] [Abstract][Full Text] [Related]
8. Selective covalent targeting of GPX4 using masked nitrile-oxide electrophiles.
Eaton JK; Furst L; Ruberto RA; Moosmayer D; Hilpmann A; Ryan MJ; Zimmermann K; Cai LL; Niehues M; Badock V; Kramm A; Chen S; Hillig RC; Clemons PA; Gradl S; Montagnon C; Lazarski KE; Christian S; Bajrami B; Neuhaus R; Eheim AL; Viswanathan VS; Schreiber SL
Nat Chem Biol; 2020 May; 16(5):497-506. PubMed ID: 32231343
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer.
Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y
J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs.
Su Y; Zhao B; Zhou L; Zhang Z; Shen Y; Lv H; AlQudsy LHH; Shang P
Cancer Lett; 2020 Jul; 483():127-136. PubMed ID: 32067993
[TBL] [Abstract][Full Text] [Related]
11. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
[TBL] [Abstract][Full Text] [Related]
12. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
[TBL] [Abstract][Full Text] [Related]
13. Apatinib induced ferroptosis by lipid peroxidation in gastric cancer.
Zhao L; Peng Y; He S; Li R; Wang Z; Huang J; Lei X; Li G; Ma Q
Gastric Cancer; 2021 May; 24(3):642-654. PubMed ID: 33544270
[TBL] [Abstract][Full Text] [Related]
14. Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential.
Huang S; Cao B; Zhang J; Feng Y; Wang L; Chen X; Su H; Liao S; Liu J; Yan J; Liang B
Cell Death Dis; 2021 Mar; 12(3):237. PubMed ID: 33664249
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of ferroptosis and its role in cancer therapy.
Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J
J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of GPX4 inhibitor warheads.
Eaton JK; Furst L; Cai LL; Viswanathan VS; Schreiber SL
Bioorg Med Chem Lett; 2020 Dec; 30(23):127538. PubMed ID: 32920142
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
18. RSL3 Drives Ferroptosis through NF-
Li S; He Y; Chen K; Sun J; Zhang L; He Y; Yu H; Li Q
Oxid Med Cell Longev; 2021; 2021():2915019. PubMed ID: 34987700
[TBL] [Abstract][Full Text] [Related]
19. GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis.
Wang Q; Bin C; Xue Q; Gao Q; Huang A; Wang K; Tang N
Cell Death Dis; 2021 Apr; 12(5):426. PubMed ID: 33931597
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer.
Zhu JM; Chen C; Kong M; Zhu L; Li YL; Zhang JF; Yu ZP; Xu SS; Kong LY; Luo JG
Eur J Med Chem; 2023 Dec; 261():115829. PubMed ID: 37801824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
